- Joined
- Jul 16, 2008
- Messages
- 22,233
- Points
- 113
Moderna might be able to roll out a reformulated vaccine against the Omicron coronavirus variant by early 2022, its CEO Paul Burton said on Nov. 28.
He added that he suspects the new Omicron coronavirus variant may elude current vaccines.
Currently, it is still not clear whether new formulations will be needed, or if existing Covid vaccinations will provide protection against the new variant that has detected in many countries around the world.
Could just take weeks to find out if current vaccines sufficient
“We should know about the ability of the current vaccine to provide protection in the next couple of weeks, but the remarkable thing about the mRNA vaccines, Moderna platform is that we can move very fast,” Burton said on the Andrew Marr Show on BBC.
“If we have to make a brand new vaccine I think that’s going to be early 2022 before that’s really going to be available in large quantities,” the Moderna chief added.
The Cambridge, Massachusetts-based biotech company mobilised "hundreds" of staff early last Thursday, Nov. 25, Thanksgiving Day in the United States, after news of the Omicron variant spread.
https://mothership.sg/2021/11/moderna-omicron-variant-vaccine/